Helminth
Strongyloides
search
Strongyloides
, Strongyloides stercoralis, Strongyloidiasis, Threadworm, Larva currens
See Also
Helminth
Parasitic Infection
Epidemiology
Nematode: Roundworm
Responsible for most U.S. cases fatal
Helminth
disease
Found in regions of poor sanitation
Endemic areas
Tropical Asia
Sub-Saharan Africa
Latin America
Pockets in Rural southeastern United States
Pockets in Eastern Europe
Pathophysiology
Soil transmitted
Helminth
On soil contact, roundworm larvae penetrate skin
Roundworms enter the venous system and are transported to the lungs
Patient coughs, and worms are swallowed, resulting in intestinal infection
Adult roundworms live in the
Small Intestine
and lay eggs
Eggs may be passed in the stool and infect soil
Eggs may also hatch and penetrate the
Small Intestine
wall, to recirculate via veins and into the lung
Larvae may also infect perianal skin
Risk Factors
Hyperinfection (
Immunocompromised
)
Chronic
Corticosteroid
use
Chemotherapy
Human Immunodeficiency Virus
(HIV)
Differential Diagnosis
Peptic Ulcer Disease
Symptoms
Often asymptomatic in immunocompetent patients
Larva currens
Recurrent serpiginous
Urticaria
and associated
Pruritus
Onset in perianal area
Migratory rash to buttocks, groin, trunk
Gastrointestinal side effects
Abdominal Pain
or
Abdominal Bloating
Diarrhea
Pulmonary involvement
Cough
Shortness of Breath
Dyspnea
Hemoptysis
Labs
Eosinophilia
(blood or stool)
May be only finding in immunocompetent patients
Guaiac-positive stools
Rhabditiform larvae present in sample
Stool
sample or duodenal aspiration
False Negative
test: 70% of cases
Management
Ivermectin
(now preferred agent)
Dose: 200 mcg/kg orally daily for 2 days
Repeat every 15 days for disseminated infection until stool testing negative (and then one more treatment)
Continuous dosing daily for hyperinfection (e.g.
Sepsis
,
Meningitis
) continued until stool and
Sputum
negative for 2 weeks
Other agents
Albendazole
400 mg orally twice daily for 7 days (for asymptomatic of intestinal infection)
Thiabendazole (not available, poorly tolerated, less effective)
Complications
Hyperinfection
Meningitis
Septic Shock
Prognosis
Hyperinfection mortality rate in immunosuppressed: 87%
References
Gilbert (2016) Sanford Guide, IOS version, accessed 9/12/2016
Siddiqui (2001) Clin Infect Dis 33:1040-7 [PubMed]
Schonau (2024) Am Fam Physician 109(6): 569-70 [PubMed]
Type your search phrase here